Multicultural Healthy Diet to Reduce Cognitive Decline & Alzheimer's Disease Risk: Study protocol for a pilot randomized controlled trial

被引:0
|
作者
Mossavar-Rahmani, Yasmin [1 ]
Shaw, Pamela A. [2 ]
Hakun, Jonathan G. [3 ,4 ,5 ,6 ]
Katz, Mindy J. [7 ]
Wylie-Rosett, Judith [8 ]
Sliwinski, Martin J. [9 ,10 ]
机构
[1] Albert Einstein Coll Med, Dept Epidemiol & Populat Hlth, Belfer Bldg 1312C,1300 Morris Pk Ave, Bronx, NY 10461 USA
[2] Kaiser Permanente Washington Hlth Res Inst, Biostat Unit, 1730 Minor Ave,Suite 1600, Seattle, WA 98101 USA
[3] Penn State Univ, Dept Neurol, Coll Med, 700 HMC Crescent Rd, Hershey, PA 17033 USA
[4] Penn State Univ, Dept Psychol, 140 Moore Bldg, University Pk, PA 16802 USA
[5] Penn State Univ, Ctr Hlth Aging, Fourth Floor Biobehav Hlth,140 Moore Bldg, University Pk, PA 16802 USA
[6] Penn State Univ, Translat Brain Res Ctr, 700 MHC Crescent Rd, Hershey, PA 17033 USA
[7] Albert Einstein Coll Med, Dept Neurol, Van Etten Bldg,Rm 3C5,1225 Morris Pk Ave, Bronx, NY 10461 USA
[8] Albert Einstein Coll Med, Dept Epidemiol & Populat Hlth, Belfer Bldg 1307, Bronx, NY 10461 USA
[9] Penn State Univ, Coll Med, Ctr Hlth Aging, University Pk, PA 16802 USA
[10] Penn State Univ, Coll Med, Dept Human Dev & Family Studies, University Pk, PA 16802 USA
基金
美国国家卫生研究院;
关键词
Ambulatory cognitive monitoring; Food record; Diet assessment; Alzheimer's disease; Cognitive function; TERM-MEMORY BINDING; EATING INDEX; RECALL; PERFORMANCE; IMPAIRMENT; DEMENTIA;
D O I
10.1016/j.cct.2022.107006
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Background: Emerging evidence indicates that healthy dietary patterns are associated with higher cognitive status; however, few clinical trials have explored this association in diverse middle-aged adults before the onset of cognitive decline. We use novel ambulatory methods to assess cognition in natural settings in tandem with diet recording. Aims: We investigate whether the Multicultural Healthy Diet Study to Reduce Cognitive Decline & Alzheimer's Disease Risk, a pilot randomized controlled trial of an anti-inflammatory dietary pattern compared to usual diet, can mitigate cognitive decline and Alzheimer's Disease risk in a diverse population of 40-65 year old adults in Bronx, New York. Methods: Primary cognitive outcomes assessed at nine months are collected in an ecological momentary assessment "measurement burst" design, over the course of participants' daily lives. These ultra-brief, ambulatory cognitive assessments examine processing speed, visuospatial working memory, short-term associative memory binding, long-term associative memory, and working memory capacity. Key secondary outcomes relate to comparing dietary intake between study arms with respect to cognitive outcomes. We assess diet with food records using the National Cancer Institute's Automated Self-Administered 24-h record and serum biomarkers. We further investigate the association of self-reported diet and dietary biomarkers with inflammatory-based biomarkers. Conclusion: This randomized controlled trial of diet and cognition for the first time combines novel measures of ambulatory cognitive assessment with web-based assessment of dietary intake recording. This new approach enabled the study to continue in the midst of the COVID-19 pandemic in remote format.
引用
下载
收藏
页数:8
相关论文
共 50 条
  • [1] Vestibular therapy to reduce falls in people with Alzheimer's disease: study protocol for a pilot randomized controlled trial
    Yesantharao, Lekha, V
    Rosenberg, Paul
    Oh, Esther
    Leoutsakos, Jeannie
    Munro, Cynthia A.
    Agrawal, Yuri
    PILOT AND FEASIBILITY STUDIES, 2022, 8 (01)
  • [2] Vestibular therapy to reduce falls in people with Alzheimer’s disease: study protocol for a pilot randomized controlled trial
    Lekha V. Yesantharao
    Paul Rosenberg
    Esther Oh
    Jeannie Leoutsakos
    Cynthia A. Munro
    Yuri Agrawal
    Pilot and Feasibility Studies, 8
  • [3] Cognitive Effects of Aerobic Exercise in Alzheimer's Disease: A Pilot Randomized Controlled Trial
    Yu, Fang
    Vock, David M.
    Zhang, Lin
    Salisbury, Dereck
    Nelson, Nathaniel W.
    Chow, Lisa S.
    Smith, Glenn
    Barclay, Terry R.
    Dysken, Maurice
    Wyman, Jean F.
    JOURNAL OF ALZHEIMERS DISEASE, 2021, 80 (01) : 233 - 244
  • [4] Can a serious game-based cognitive training attenuate cognitive decline related to Alzheimer’s disease? Protocol for a randomized controlled trial
    Esther Brill
    Christine Krebs
    Michael Falkner
    Jessica Peter
    Katharina Henke
    Marc Züst
    Lora Minkova
    Anna-Katharine Brem
    Stefan Klöppel
    BMC Psychiatry, 22
  • [5] Can a serious game-based cognitive training attenuate cognitive decline related to Alzheimer's disease? Protocol for a randomized controlled trial
    Brill, Esther
    Krebs, Christine
    Falkner, Michael
    Peter, Jessica
    Henke, Katharina
    Zuest, Marc
    Minkova, Lora
    Brem, Anna-Katharine
    Kloeppel, Stefan
    BMC PSYCHIATRY, 2022, 22 (01)
  • [6] A 12-week multidomain intervention versus active control to reduce risk of Alzheimer’s disease: study protocol for a randomized controlled trial
    Kaarin J Anstey
    Alex Bahar-Fuchs
    Pushpani Herath
    George W Rebok
    Nicolas Cherbuin
    Trials, 14
  • [7] A 12-week multidomain intervention versus active control to reduce risk of Alzheimer's disease: study protocol for a randomized controlled trial
    Anstey, Kaarin J.
    Bahar-Fuchs, Alex
    Herath, Pushpani
    Rebok, George W.
    Cherbuin, Nicolas
    TRIALS, 2013, 14
  • [8] The effect of electroacupuncture combined with donepezil on cognitive function in Alzheimer’s disease patients: study protocol for a randomized controlled trial
    Weina Peng
    Jing Zhou
    Min Xu
    Qing Feng
    Lulu Bin
    Zhishun Liu
    Trials, 18
  • [9] The effect of electroacupuncture combined with donepezil on cognitive function in Alzheimer's disease patients: study protocol for a randomized controlled trial
    Peng, Weina
    Zhou, Jing
    Xu, Min
    Feng, Qing
    Bin, Lulu
    Liu, Zhishun
    TRIALS, 2017, 18
  • [10] Aerobic exercise for Alzheimer's disease: A randomized controlled pilot trial
    Morris, Jill K.
    Vidoni, Eric D.
    Johnson, David K.
    Van Sciver, Angela
    Mahnken, Jonathan D.
    Honea, Robyn A.
    Wilkins, Heather M.
    Brooks, William M.
    Billinger, Sandra A.
    Swerdlow, Russell H.
    Burns, Jeffrey M.
    PLOS ONE, 2017, 12 (02):